Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VERAVera Therapeutics, Inc.

Nasdaq · CIK 0001831828
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts299

Identity from submissions API

NameVera Therapeutics, Inc.
CIK0001831828
TickersVERA
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN812744449
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-770-0077
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE
CA
94005
CA
Mailing address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE
CA
94005
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

480 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000722 005-92556 261556489 34 7821
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-004552 005-92556 261555915 34 10726
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005080 005-92556 261555813 34 11397
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000740 005-92556 261538390 34 8060
2026-11-05 10-Q 10-Q 0001193125-26-449826 001-40407 261527402 34 11580251 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-449780 001-40407 261527226 34 777288 1 1
2026-09-17 4 xslF345X06/form4-09172026_080936.xml 0001859453-26-000015 8787
2026-09-15 8-K 8-K 7.01,8.01,9.01 0001193125-26-391280 001-40407 261379101 34 11190591 1 1
2026-09-14 4 xslF345X06/form4-09142026_080921.xml 0001861684-26-000006 7044
2026-09-04 4 xslF345X06/form4-09042026_040901.xml 0001859453-26-000014 9248
2026-09-02 144 xsl144X01/primary_doc.xml 0001950047-26-009028 001-40407 261355381 33 6551
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001907884-26-000015 005-92556 261278622 34 9578
2026-08-12 4/A xslF345X06/form4a-08122026_100831.xml 0001859453-26-000013 15803
2026-08-12 4/A xslF345X06/form4a-08122026_100823.xml 0001859453-26-000012 11306
2026-08-12 4/A xslF345X06/form4a-08122026_100809.xml 0001859453-26-000011 11764
2026-08-10 10-Q 10-Q 0001193125-26-342380 001-40407 261258500 34 9844826 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-342335 001-40407 261258346 34 737990 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000554 005-92556 261252409 34 8089
2026-08-05 4 xslF345X06/form4-08052026_080802.xml 0002145711-26-000002 7691
2026-08-05 3 xslF345X06/form3-08052026_080847.xml 0002145711-26-000001 9905
2026-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003123 005-92556 261221075 34 11125
2026-07-09 4 xslF345X06/form4-07092026_040701.xml 0001859453-26-000010 12793
2026-07-09 8-K 8-K 5.02 0001193125-26-299165 001-40407 261164007 34 144500 1 1
2026-07-07 8-K 8-K 8.01 0001193125-26-297211 001-40407 261158630 34 144062 1 1
2026-06-24 4 xslF345X06/form4-06242026_080643.xml 0001859453-26-000008 8379
2026-06-23 144 xsl144X01/primary_doc.xml 0001950047-26-006433 001-40407 261111423 33 6554
2026-06-02 8-K 8-K 8.01 0001193125-26-252475 001-40407 261053599 34 148865 1 1
2026-05-26 8-K 8-K 5.07 0001193125-26-239559 001-40407 261020817 34 173697 1 1
2026-05-26 4 xslF345X06/form4-05262026_080514.xml 0001662426-26-000002 5884
2026-05-26 4 xslF345X06/form4-05262026_080555.xml 0001778307-26-000002 5854
2026-05-26 4 xslF345X06/form4-05262026_080559.xml 0001184592-26-000002 5834
2026-05-26 4 xslF345X06/form4-05262026_080547.xml 0001822092-26-000005 5832
2026-05-26 4 xslF345X06/form4-05262026_080541.xml 0001387521-26-000002 5849
2026-05-26 4 xslF345X06/form4-05262026_080529.xml 0001897965-26-000002 5864
2026-05-26 4 xslF345X06/form4-05262026_080523.xml 0001202096-26-000002 6031
2026-05-26 4 xslF345X06/form4-05262026_080520.xml 0001253886-26-000004 5874
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000426 005-92556 26983467 34 7741
2026-05-13 4 xslF345X06/form4-05132026_080543.xml 0001859453-26-000007 8837
2026-05-12 144 xsl144X01/primary_doc.xml 0001950047-26-004408 001-40407 26969200 33 6302
2026-05-07 10-Q 10-Q 0001193125-26-212143 001-40407 26954166 34 9808351 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210351 001-40407 26950879 34 677334 1 1
2026-04-15 4 xslF345X06/form4-04152026_080434.xml 0001859453-26-000006 11019
2026-04-14 144 xsl144X01/primary_doc.xml 0001950047-26-003436 001-40407 26861192 33 5570
2026-04-09 ARS ARS 0001140361-26-014008 001-40407 26851633 34 5261284
2026-04-09 DEFA14A DEFA14A 0001140361-26-014006 001-40407 26851619 34 1347188
2026-04-09 DEF 14A DEF 14A 0001140361-26-014002 001-40407 26851605 34 6335351 1 1
2026-04-01 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-001831 005-92556 26829627 34 18268
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002499 005-92556 26805061 34 7168
2026-03-25 4 xslF345X06/form4-03252026_110324.xml 0001614568-26-000008 7790
2026-03-25 3 xslF345X06/form3-03252026_110337.xml 0001614568-26-000007 8752
2026-03-16 4 xslF345X05/form4-03162026_100309.xml 0001861684-26-000005 7080
2026-03-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001342 005-92556 26743257 34 11176
2026-03-09 8-K 8-K 5.02 0001193125-26-098783 001-40407 26735975 34 148483 1 1
2026-03-09 4 xslF345X05/form4-03092026_080317.xml 0001814238-26-000005 5431
2026-03-09 3 xslF345X02/form3-03092026_080309.xml 0001814238-26-000004 8220
2026-03-05 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-023756 005-92556 26724087 34 45673
2026-02-27 S-8 S-8 0001193125-26-078157 333-293830 26691604 33 227203 1 1
2026-02-26 10-K 10-K 0001193125-26-077442 001-40407 26690649 34 27336106 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-073421 001-40407 26681708 34 696300 1 1
2026-02-25 4 xslF345X05/form4-02262026_010204.xml 0002006910-26-000004 6040
2026-02-25 4 xslF345X05/form4-02262026_010213.xml 0001861684-26-000004 6027
2026-02-25 4 xslF345X05/form4-02262026_120222.xml 0001872792-26-000004 6727
2026-02-25 4 xslF345X05/form4-02262026_120224.xml 0001859453-26-000004 7427
2026-02-25 4 xslF345X05/form4-02262026_120221.xml 0001733883-26-000006 6049
2026-02-25 4 xslF345X05/form4-02262026_120218.xml 0001819688-26-000005 6044
2026-02-25 4 xslF345X05/form4-02262026_120224.xml 0002108080-26-000004 6034
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001670 001-40407 26665963 33 4750
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001669 001-40407 26665950 33 4766
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001668 001-40407 26665936 33 4751
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001667 001-40407 26665918 33 4758
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001661 001-40407 26665766 33 4766
2026-02-23 144 xsl144X01/primary_doc.xml 0001950047-26-001646 001-40407 26665669 33 4766
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-26-000281 005-92556 26637736 34 7625
2026-02-06 4 xslF345X05/form4-02062026_080213.xml 0001861684-26-000002 7549
2026-02-06 4 xslF345X05/form4-02062026_080211.xml 0001859453-26-000002 9461
2026-02-06 4 xslF345X05/form4-02062026_080209.xml 0001872792-26-000002 8453
2026-02-06 4 xslF345X05/form4-02062026_080207.xml 0002108080-26-000002 7552
2026-02-06 4 xslF345X05/form4-02062026_080205.xml 0001819688-26-000002 7562
2026-02-06 4 xslF345X05/form4-02062026_080203.xml 0001733883-26-000002 7841
2026-02-06 4 xslF345X05/form4-02062026_080201.xml 0002006910-26-000002 7762
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000540 005-92556 26602071 34 11477
2026-01-30 3 3 0001193125-26-031763 22195
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000262 005-92556 26582596 34 6966
2025-12-18 8-K 8-K 5.02 0001193125-25-323298 001-40407 251580976 34 134460 1 1
2025-12-17 4 4 0001193125-25-322691 8881
2025-12-15 4 4 0001193125-25-319649 7501
2025-12-15 144 xsl144X01/primary_doc.xml 0001950047-25-010312 001-40407 251571816 33 6240
2025-12-10 8-K 8-K 8.01,9.01 0001193125-25-314430 001-40407 251562803 34 442557 1 1
2025-12-10 424B5 424B5 0001193125-25-314244 333-282861 251562276 33 690594 1 1
2025-12-10 4 4 0001193125-25-314156 8881
2025-12-08 144 xsl144X01/primary_doc.xml 0001950047-25-009958 001-40407 251556621 33 5509
2025-12-08 424B5 424B5 0001193125-25-311219 333-282861 251556169 33 557623
2025-12-04 4 4 0001193125-25-308074 8355
2025-12-03 144 xsl144X01/primary_doc.xml 0001950047-25-009711 001-40407 251546883 33 4781
2025-11-26 4 4 0001193125-25-300677 5392
2025-11-26 3 3 0001193125-25-300675 14973
2025-11-26 8-K 8-K 5.02 0001193125-25-300647 001-40407 251530793 34 150582 1 1
2025-11-25 4 4 0001193125-25-297161 5055
2025-11-24 144 xsl144X01/primary_doc.xml 0001193125-25-294092 001-40407 251514874 33 4262
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-25-000840 005-92556 251483448 34 7625
2025-11-13 4 4 0001193125-25-280792 8681
2025-11-06 8-K 8-K 8.01,9.01 0001193125-25-268331 001-40407 251456646 34 710545 1 1
2025-11-05 10-Q 10-Q 0001193125-25-266881 001-40407 251453886 34 10681766 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265799 001-40407 251451854 34 721760 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-005108 005-92556 251215588 34 9314
2025-08-05 8-K 8-K 1.01,1.02,9.01 0001193125-25-173591 001-40407 251185845 34 401300 1 1
2025-08-05 424B5 424B5 0001193125-25-173588 333-282861 251185803 33 657862 1 1
2025-08-05 10-Q 10-Q 0000950170-25-103022 001-40407 251184946 34 10047785 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102399 001-40407 251182808 34 668512 1 1
2025-06-25 4 4 0000950170-25-090110 11927
2025-06-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-000870 005-92556 251041041 34 16647
2025-06-03 8-K 8-K 1.01,2.03,9.01 0001193125-25-133730 001-40407 251017110 34 546702 1 1
2025-06-02 8-K 8-K 7.01,8.01,9.01 0001193125-25-132736 001-40407 251013085 34 10661377 1 1
2025-05-19 8-K 8-K 5.07 0000950170-25-074446 001-40407 25964597 34 182071 1 1
2025-05-16 4 xslF345X05/form4-05162025_080547.xml 0001415889-25-013423 5717
2025-05-16 4 xslF345X05/form4-05162025_080556.xml 0001415889-25-013421 5736
2025-05-16 4 xslF345X05/form4-05162025_080502.xml 0001415889-25-013420 5679
2025-05-16 4 xslF345X05/form4-05162025_080509.xml 0001415889-25-013419 5893
2025-05-16 4 xslF345X05/form4-05162025_080516.xml 0001415889-25-013417 5696
2025-05-16 4 xslF345X05/form4-05162025_080530.xml 0001415889-25-013415 5726
2025-05-16 4 xslF345X05/form4-05162025_080528.xml 0001415889-25-013412 5746
2025-05-16 4 xslF345X05/form4-05162025_080509.xml 0001415889-25-013408 5726
2025-05-07 10-Q 10-Q 0000950170-25-064733 001-40407 25918754 34 8764880 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-063975 001-40407 25915296 34 681422 1 1
2025-04-03 ARS ARS 0001140361-25-012039 001-40407 25809507 34 4150678
2025-04-03 DEFA14A DEFA14A 0001140361-25-012036 001-40407 25809473 34 11269297
2025-04-03 DEF 14A DEF 14A 0001140361-25-012034 001-40407 25809418 34 5708002 1 1
2025-02-28 S-8 S-8 0001193125-25-042606 333-285445 25691310 33 286906 1 1
2025-02-28 10-K 10-K 0000950170-25-029969 001-40407 25689821 34 30159256 1 1
2025-02-27 4 xslF345X05/form4-02272025_090225.xml 0001415889-25-005841 10798
2025-02-26 144 xsl144X01/primary_doc.xml 0001950047-25-001279 001-40407 25670401 33 7049
2025-02-26 8-K 8-K 2.02,9.01 0000950170-25-027337 001-40407 25666214 34 386032 1 1
2025-02-20 4 xslF345X05/form4-02202025_090211.xml 0001415889-25-004851 7547
2025-02-20 4 xslF345X05/form4-02202025_090246.xml 0001415889-25-004849 7561
2025-02-20 4 xslF345X05/form4-02202025_090217.xml 0001415889-25-004847 7764
2025-02-20 4 xslF345X05/form4-02202025_090254.xml 0001415889-25-004846 8242
2025-02-20 4 xslF345X05/form4-02202025_090218.xml 0001415889-25-004845 8252
2025-02-20 4 xslF345X05/form4-02202025_090230.xml 0001415889-25-004844 7565
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000985 005-92556 25623917 34 10646
2025-01-13 8-K 8-K 7.01,9.01 0001193125-25-005010 001-40407 25524909 34 10487959 1 1
2025-01-10 4 xslF345X05/form4-01102025_090146.xml 0001415889-25-001242 18357
2025-01-08 144 xsl144X01/primary_doc.xml 0001950047-25-000187 001-40407 25518794 33 9476
2024-12-20 4 xslF345X05/form4-12202024_091238.xml 0001415889-24-029964 28880
2024-12-18 144 xsl144X01/primary_doc.xml 0001950047-24-009959 001-40407 241559489 33 9250
2024-12-13 4 xslF345X05/form4-12132024_091242.xml 0001415889-24-029275 21811
2024-12-11 144 xsl144X01/primary_doc.xml 0001950047-24-009703 001-40407 241542232 33 8520
2024-11-27 4 xslF345X05/form4-11272024_091139.xml 0001415889-24-027840 26934
2024-11-25 144 xsl144X01/primary_doc.xml 0001950047-24-009075 001-40407 241496541 33 9254
2024-11-20 4 xslF345X05/form4-11202024_091116.xml 0001415889-24-027332 7421
2024-11-20 3 xslF345X02/form3-11202024_091109.xml 0001415889-24-027331 9762
2024-11-15 4 xslF345X05/form4-11152024_091112.xml 0001415889-24-026944 46584
2024-11-14 SC 13G/A formsc13ga.htm 0001493152-24-045861 005-92556 241462202 34 98383
2024-11-14 SC 13G/A formsc13ga.htm 0001493152-24-045842 005-92556 241461868 34 98196
2024-11-14 SC 13G vera13gsep24.txt 0000080255-24-001473 005-92556 34 6463
2024-11-14 SC 13G/A KYNAM CAPITAL MANAGEMENT, LP 0001085146-24-005820 005-92556 241459248 34 44239
2024-11-14 SC 13G VERA THERAPEUTICS, INC. 0000902664-24-006527 005-92556 241457831 34 61609
2024-11-13 144 xsl144X01/primary_doc.xml 0001950047-24-008508 001-40407 241454672 33 9249
2024-11-12 SC 13G/A filing.txt 0000315066-24-002869 005-92556 241444963 34 8124
2024-11-07 10-Q 10-Q 0000950170-24-123239 001-40407 241435341 34 8367865 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122814 001-40407 241433260 34 312399 1 1
2024-11-04 SC 13D/A SC 13D/A 0001193125-24-250796 005-92556 241425230 34 115616
2024-10-31 8-K 8-K 8.01,9.01 0001193125-24-248079 001-40407 241412199 34 468432 1 1
2024-10-30 424B5 424B5 0001193125-24-247568 333-282861 241410533 33 903938
2024-10-30 4 xslF345X05/form4-10302024_081020.xml 0001415889-24-025746 8035
2024-10-29 424B5 424B5 0001193125-24-245751 333-282861 241402516 33 745807
2024-10-28 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-24-245704 001-40407 241402089 34 9185687 1 1
2024-10-28 S-3ASR S-3ASR 0001193125-24-245701 333-282861 241402050 33 1059788
2024-10-28 144 xsl144X01/primary_doc.xml 0001950047-24-007911 001-40407 241401389 33 6905
2024-10-25 4 xslF345X05/form4-10252024_081055.xml 0001415889-24-025634 23229
2024-10-23 144 xsl144X01/primary_doc.xml 0001950047-24-007852 001-40407 241389426 33 8478
2024-10-11 4 xslF345X05/form4-10112024_081019.xml 0001415889-24-025024 12523
2024-10-09 144 xsl144X01/primary_doc.xml 0001950047-24-007640 001-40407 241362979 33 7753
2024-10-02 8-K 8-K 7.01,9.01 0001193125-24-230760 001-40407 241345430 34 16565031 1 1
2024-09-27 4 xslF345X05/form4-09272024_080904.xml 0001415889-24-024033 50482
2024-09-25 144 xsl144X01/primary_doc.xml 0001950047-24-007388 001-40407 241324543 33 7025
2024-09-20 4 xslF345X05/form4-09202024_080929.xml 0001415889-24-023779 10415
2024-09-18 144 xsl144X01/primary_doc.xml 0001950047-24-007226 001-40407 241308016 33 4665
2024-09-18 144 xsl144X01/primary_doc.xml 0001950047-24-007224 001-40407 241308012 33 4870
2024-09-13 4 xslF345X05/form4-09132024_080943.xml 0001415889-24-023372 12521
2024-09-11 144 xsl144X01/primary_doc.xml 0001950047-24-006960 001-40407 241292867 33 6533
2024-08-30 4 xslF345X05/form4-08302024_080840.xml 0001415889-24-022620 16475
2024-08-28 144 xsl144X01/primary_doc.xml 0001950047-24-006580 001-40407 241255664 33 6161
2024-08-23 4 xslF345X05/form4-08232024_090800.xml 0001415889-24-022150 5384
2024-08-16 4 xslF345X05/form4-08162024_080827.xml 0001415889-24-021460 9270
2024-08-14 144 xsl144X01/primary_doc.xml 0001950047-24-006014 001-40407 241208397 33 4851
2024-08-08 10-Q 10-Q 0000950170-24-094108 001-40407 241189083 34 8363733 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093342 001-40407 241186125 34 309856 1 1
2024-07-03 4 xslF345X05/form4-07032024_080715.xml 0001415889-24-019162 5513
2024-07-03 3 xslF345X02/form3-07032024_080700.xml 0001415889-24-019158 8722
2024-07-02 8-K 8-K 5.02,9.01 0001193125-24-174318 001-40407 241095137 34 453434 1 1
2024-06-12 8-K 8-K 5.02 0001193125-24-159935 001-40407 241038420 34 151560 1 1
2024-06-11 4 xslF345X05/form4-06112024_080614.xml 0001415889-24-016358 5405
2024-06-11 3 xslF345X02/form3-06112024_080657.xml 0001415889-24-016354 9677
2024-05-17 8-K 8-K 5.07 0000950170-24-061872 001-40407 24961310 34 178241 1 1
2024-05-17 4 xslF345X05/form4-05172024_080555.xml 0001415889-24-013504 19053
2024-05-17 4 xslF345X05/form4-05172024_080552.xml 0001415889-24-013498 5571
2024-05-17 4 xslF345X05/form4-05172024_080541.xml 0001415889-24-013490 5738
2024-05-17 4 xslF345X05/form4-05172024_080522.xml 0001415889-24-013478 5885
2024-05-17 4 xslF345X05/form4-05172024_080515.xml 0001415889-24-013476 5714
2024-05-17 4 xslF345X05/form4-05172024_080545.xml 0001415889-24-013473 5718
2024-05-17 4 xslF345X05/form4-05172024_080506.xml 0001415889-24-013472 5733
2024-05-17 4 xslF345X05/form4-05172024_080535.xml 0001415889-24-013470 5718
2024-05-10 10-Q 10-Q 0000950170-24-057292 001-40407 24932141 34 7919863 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056283 001-40407 24928584 34 286696 1 1
2024-05-03 DEFA14A DEFA14A 0001193125-24-130666 001-40407 24912873 34 13616
2024-04-12 4 xslF345X05/form4-04122024_080416.xml 0001415889-24-010753 4815
2024-04-05 4 xslF345X05/form4-04062024_010405.xml 0001415889-24-010473 39905
2024-04-05 4 xslF345X05/form4-04062024_010432.xml 0001415889-24-010472 13943
2024-04-04 ARS ARS 0001140361-24-017732 001-40407 24821477 34 4010628
2024-04-03 DEFA14A DEFA14A 0001140361-24-017652 001-40407 24819836 34 3593965
2024-04-03 DEF 14A DEF 14A 0001140361-24-017650 001-40407 24819818 34 2216951
2024-04-03 144 xsl144X01/primary_doc.xml 0001974078-24-000148 001-40407 24818924 33 7385
2024-03-27 S-8 S-8 0001193125-24-078822 333-278277 24790824 33 105448
2024-03-27 10-K 10-K 0000950170-24-036729 001-40407 24785485 34 17106438 1 1
2024-03-26 SC 13D/A SC 13D/A 0001104659-24-039188 005-92556 24785393 34 135328
2024-03-25 4 OWNERSHIP DOCUMENT 0001104659-24-038589 17647
2024-03-21 144 xsl144X01/primary_doc.xml 0001968582-24-000241 001-40407 24772076 33 4475
2024-03-20 8-K 8-K 2.02,9.01 0000950170-24-033947 001-40407 24766286 34 294573 1 1
2024-02-20 SC 13D/A SC 13D/A 0001104659-24-025676 005-92556 24655775 34 131311
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023924 005-92556 24639963 34 137670
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006666 005-92556 24638150 34 98298
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006601 005-92556 24637722 34 98272
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023492 005-92556 24636741 34 141670
2024-02-14 SC 13G/A KYNAM CAPITAL MANAGEMENT, LP 0001085146-24-001352 005-92556 24635165 34 44229
2024-02-12 SC 13G p24-0709sc13g.htm 0000902664-24-001434 005-92556 24620635 34 52214
2024-02-09 SC 13G/A filing.txt 0000315066-24-001585 005-92556 24612694 34 8101
2024-02-05 SC 13D/A SC 13D/A 0001193125-24-024125 005-92556 24596441 34 117387
2024-02-01 4 OWNERSHIP DOCUMENT 0001104659-24-009537 5701
2024-01-30 8-K 8-K 8.01,9.01 0001193125-24-019496 001-40407 24578932 34 433131 1 1
2024-01-30 424B5 424B5 0001193125-24-019492 333-265408 24578897 33 721219
2024-01-29 S-3MEF S-3MEF 0001193125-24-018532 333-276761 24575602 33 55033
2024-01-29 SC 13G us92337r1014_012924.txt 0001086364-24-005502 005-92556 24574901 34 13463
2024-01-29 144 xsl144X01/primary_doc.xml 0001950047-24-000497 001-40407 24574068 33 4732
2024-01-29 424B5 424B5 0001193125-24-017530 333-265408 24570560 33 722857
2024-01-29 8-K 8-K 2.02,8.01 0001193125-24-017311 001-40407 24569969 34 153819 1 1
2024-01-25 8-K 8-K 7.01,8.01,9.01 0001193125-24-014808 001-40407 24558504 34 19926863 1 1
2024-01-18 4 xslF345X05/form4-01182024_090156.xml 0001415889-24-001526 7542
2024-01-18 4 xslF345X05/form4-01182024_090112.xml 0001415889-24-001518 7740
2024-01-18 4 xslF345X05/form4-01182024_090121.xml 0001415889-24-001514 10517
2024-01-12 4 xslF345X05/ownership.xml 0001493152-24-002290 5815
2024-01-09 4 FORM 4 SUBMISSION 0001209191-24-001231 5561
2024-01-09 3 FORM 3 SUBMISSION 0001209191-24-001229 6888
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001087 5550
2024-01-08 3 FORM 3 SUBMISSION 0001209191-24-001086 7267
2024-01-08 8-K 8-K 5.02,7.01,9.01 0001193125-24-003931 001-40407 24518428 34 185049 1 1
2024-01-08 8-K 8-K 7.01,9.01 0001193125-24-003928 001-40407 24518419 34 14157975 1 1
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000352 10920
2023-12-26 8-K 8-K 2.03 0001193125-23-303004 001-40407 231513322 34 151119 1 1
2023-11-13 SC 13G/A filing.txt 0000315066-23-002759 005-92556 231395636 34 8123
2023-11-09 10-Q 10-Q 0000950170-23-062139 001-40407 231393077 34 8647304 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-061548 001-40407 231390125 34 355259 1 1
2023-08-23 4 FORM 4 SUBMISSION 0001209191-23-047105 5347
2023-08-23 4 FORM 4 SUBMISSION 0001209191-23-047103 5588
2023-08-23 4 FORM 4 SUBMISSION 0001209191-23-047102 5589
2023-08-10 10-Q 10-Q 0000950170-23-041399 001-40407 231160085 34 9809234 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040973 001-40407 231157248 34 364766 1 1
2023-08-02 SC 13D/A SC 13D/A 0001193125-23-201784 005-92556 231136748 34 198887
2023-07-06 4 FORM 4 SUBMISSION 0001209191-23-041521 6964
2023-07-05 SC 13D/A SC 13D/A 0001193125-23-181969 005-92556 231069201 34 200268
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039323 7356
2023-06-22 4 xslF345X04/ownership.xml 0001493152-23-022130 6261
2023-06-22 3 xslF345X02/ownership.xml 0001493152-23-022128 4784
2023-06-20 8-K 8-K 7.01,8.01,9.01 0001193125-23-169612 001-40407 231023412 34 11175062 1 1
2023-05-17 8-K 8-K 5.07 0001193125-23-146313 001-40407 23929387 34 157788 1 1
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029038 8646
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029034 8972
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029031 8811
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029024 8762
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029018 8783
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029014 8809
2023-05-12 4 FORM 4 SUBMISSION 0001209191-23-029008 8782
2023-05-11 10-Q 10-Q 0000950170-23-021335 001-40407 23911733 34 8982162 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020841 001-40407 23908835 34 345523 1 1
2023-04-13 SC 13D/A SC 13D/A 0001193125-23-100524 005-92556 23818429 34 186880
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022150 5953
2023-03-30 ARS ARS 0000950170-23-011016 001-40407 23781596 34 3627160
2023-03-30 DEFA14A DEFA14A 0001140361-23-014836 001-40407 23781012 34 3248497
2023-03-30 DEF 14A DEF14A 0001140361-23-014835 001-40407 23781008 34 2164778
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021609 5956
2023-03-28 S-8 S-8 0001193125-23-082342 333-270911 23770728 33 83149
2023-03-28 10-K 10-K 0000950170-23-010288 001-40407 23769704 34 15165823 1 1
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021386 8912
2023-03-28 8-K 8-K 2.02,9.01 0000950170-23-010114 001-40407 23766160 34 368397 1 1
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020280 8919
2023-03-17 4 FORM 4 SUBMISSION 0001209191-23-019611 8888
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018409 5925
2023-03-10 8-K 8-K 8.01 0001193125-23-067568 001-40407 23723509 34 150217 1 1
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016702 5917
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015418 8500
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013159 5915
2023-02-17 4/A FORM 4/A SUBMISSION 0001209191-23-010595 5213
2023-02-17 4/A FORM 4/A SUBMISSION 0001209191-23-010583 5217
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010554 5455
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010542 5450
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010523 5443
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010510 5439
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010491 5449
2023-02-16 SC 13D/A SC 13D/A 0001193125-23-041133 005-92556 23639002 34 130845
2023-02-16 SC 13G formsc13g.htm 0001493152-23-005323 005-92556 23638534 34 104879
2023-02-15 4 FORM 4 SUBMISSION 0001209191-23-009873 5926
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021805 005-92556 23630727 34 78383
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020723 005-92556 23622658 34 137928
2023-02-14 SC 13D/A SC 13D/A 0001104659-23-020136 005-92556 23621398 34 127958
2023-02-13 4 FORM 4 SUBMISSION 0001209191-23-008685 5540
2023-02-10 SC 13G KYNAM CAPITAL MANAGEMENT, LP 0001085146-23-001012 005-92556 23610133 34 43679
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008025 13135
2023-02-09 SC 13G/A filing.txt 0000315066-23-002102 005-92556 23605139 34 8137
2023-02-08 4 FORM 4 SUBMISSION 0000899243-23-004349 13948
2023-02-08 4 FORM 4 SUBMISSION 0000899243-23-004345 6953
2023-02-08 3 FORM 3 SUBMISSION 0000899243-23-004342 7094
2023-02-08 4 OWNERSHIP DOCUMENT 0001104659-23-014661 22048
2023-02-08 4 FORM 4 SUBMISSION 0001209191-23-007770 4962
2023-02-08 4 FORM 4 SUBMISSION 0001209191-23-007769 7739
2023-02-06 SC 13D/A SC 13D/A 0001104659-23-010752 005-92556 23587926 34 128855
2023-02-03 SC 13G/A SC 13G/A 0001104659-23-010691 005-92556 23587427 34 60946
2023-02-02 8-K 8-K 8.01,9.01 0001193125-23-022827 001-40407 23582031 34 432264 1 1
2023-02-02 424B5 424B5 0001193125-23-022820 333-265408 23581997 33 553641
2023-02-01 424B5 424B5 0001193125-23-021537 333-265408 23576819 33 557345
2023-02-01 8-K 8-K 2.02 0001193125-23-021527 001-40407 23576740 34 150139 1 1
2023-01-30 8-K 8-K 7.01,8.01,9.01 0001193125-23-018203 001-40407 23565111 34 10505262 1 1
2023-01-27 SC 13G/A SC 13G/A 0001104659-23-007194 005-92556 23559577 34 136892
2023-01-03 8-K 8-K 7.01,8.01,9.01 0001193125-23-000830 001-40407 23502862 34 11085972 1 1
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061973 12706
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061178 20317
2022-12-08 4 FORM 4 SUBMISSION 0001209191-22-060331 4772
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058095 15037
2022-11-17 4 FORM 4 SUBMISSION 0001209191-22-057513 10812
2022-11-10 4 FORM 4 SUBMISSION 0001209191-22-056364 4772
2022-11-09 10-Q 10-Q 0000950170-22-023932 001-40407 221373226 34 10375129 1 1
2022-11-09 8-K 8-K 2.02,9.01 0000950170-22-023518 001-40407 221370673 34 389665 1 1
2022-10-20 4 FORM 4 SUBMISSION 0001209191-22-054192 24023
2022-10-06 4 FORM 4 SUBMISSION 0001209191-22-052972 4772
2022-10-05 4 FORM 4 SUBMISSION 0001209191-22-052719 25582
2022-09-22 4 FORM 4 SUBMISSION 0001209191-22-051002 40449
2022-09-14 4 FORM 4 SUBMISSION 0001209191-22-049902 12713
2022-09-13 4/A FORM 4/A SUBMISSION 0001209191-22-049685 6005
2022-09-13 4 FORM 4 SUBMISSION 0001209191-22-049681 18462
2022-09-09 4 FORM 4 SUBMISSION 0001209191-22-049316 14891
2022-09-09 8-K 8-K 1.01,8.01,9.01 0001193125-22-241970 001-40407 221236371 34 205324 1 1
2022-09-09 424B5 424B5 0001193125-22-241471 333-265408 221235067 33 353334
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049176 4774
2022-09-06 4 FORM 4 SUBMISSION 0001209191-22-048746 18461
2022-08-23 4 FORM 4 SUBMISSION 0001209191-22-047172 46063
2022-08-23 4 FORM 4 SUBMISSION 0001209191-22-047170 8155
2022-08-23 4 FORM 4 SUBMISSION 0001209191-22-047167 8335
2022-08-23 4 FORM 4 SUBMISSION 0001209191-22-047164 7774
2022-08-23 4 FORM 4 SUBMISSION 0001209191-22-047162 8173
2022-08-19 4 FORM 4 SUBMISSION 0000899243-22-029282 31591
2022-08-15 4 FORM 4 SUBMISSION 0001209191-22-045806 9148
2022-08-11 SC 13D/A SC 13D/A 0001193125-22-218676 005-92556 221156803 34 227804
2022-08-11 3 FORM 3 SUBMISSION 0000899243-22-028385 20135
2022-08-10 10-Q 10-Q 0000950170-22-016498 001-40407 221152269 34 9496639 1 1
2022-08-10 8-K 8-K 2.02,9.01 0000950170-22-016259 001-40407 221150412 34 382932 1 1
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044412 4774
2022-07-20 4 FORM 4 SUBMISSION 0001209191-22-042675 21273
2022-07-15 4 FORM 4 SUBMISSION 0001209191-22-042255 11172
2022-07-11 4 FORM 4 SUBMISSION 0001209191-22-041771 16236
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-039055 11171
2022-06-21 4 FORM 4 SUBMISSION 0001209191-22-038582 17064
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037401 14162
2022-06-14 424B5 424B5 0001193125-22-173117 333-265408 221012840 33 170805
2022-06-14 424B5 424B5 0001193125-22-173113 333-265408 221012828 33 285645
2022-06-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-06-13 16:30:00 9999999995-22-001773 333-265408 221013344 33 1692
2022-06-09 UPLOAD filename1.pdf 0000000000-22-006332 40198
2022-06-09 CORRESP filename1.htm 0001193125-22-171047 8253
2022-06-03 S-3 S-3 0001193125-22-167319 333-265408 22994503 33 1295254
2022-06-02 4 FORM 4 SUBMISSION 0001209191-22-033485 9315
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032189 5601
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032186 5609
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032181 5624
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032176 5592
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032168 5629
2022-05-26 4 FORM 4 SUBMISSION 0001209191-22-032159 5462
2022-05-26 8-K 8-K 5.07 0001193125-22-160307 001-40407 22965516 34 154655 1 1
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031857 5511
2022-05-25 3 FORM 3 SUBMISSION 0001209191-22-031851 6896
2022-05-16 10-Q 10-Q 0000950170-22-010094 001-40407 22929549 34 8435208 1 1
2022-05-16 8-K 8-K 2.02,9.01 0000950170-22-009943 001-40407 22925484 34 398327 1 1
2022-04-14 DEFA14A DEFA14A 0001140361-22-014570 001-40407 22827228 34 820420
2022-04-14 DEF 14A DEF14A 0001140361-22-014566 001-40407 22827201 34 2059639
2022-04-12 8-K 8-K 5.02 0001193125-22-102911 001-40407 22822257 34 151983 1 1
2022-04-07 SC 13D/A AMENDMENT NO.1 0000905718-22-000551 005-92556 22814348 34 43565
2022-04-05 SC 13D/A SC 13D/A 0001193125-22-095610 005-92556 22805204 34 84781
2022-04-05 4 FORM 4 SUBMISSION 0000899243-22-013598 9130
2022-04-05 4 FORM 4 SUBMISSION 0000899243-22-013596 5531
2022-03-28 S-8 S-8 0001193125-22-086751 333-263899 22775951 33 79828
2022-03-28 10-K 10-K 0000950170-22-004701 001-40407 22772751 34 13130702 1 1
2022-03-24 8-K 8-K 2.02,9.01 0000950170-22-004476 001-40407 22764698 34 419703 1 1
2022-02-24 SC 13G VERA THERAPEUTICS, INC. 0001104659-22-026621 005-92556 22671566 34 75947
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011224 5448
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011222 5437
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011220 5438
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011215 5441
2022-02-18 4 FORM 4 SUBMISSION 0001209191-22-011212 5450
2022-02-14 4 FORM 4 0001104659-22-023301 10386
2022-02-14 SC 13G/A VERA THERAPEUTICS, INC. 0001104659-22-021373 005-92556 22624907 34 139190
2022-02-11 424B4 424B4 0001193125-22-037414 333-262569 22622776 33 7295034
2022-02-11 SC 13G SCHEDULE 13G 0001104659-22-020616 005-92556 22622155 34 65997
2022-02-10 S-1MEF S-1MEF 0001193125-22-033630 333-262618 22609638 33 67672
2022-02-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-02-09 16:30:00 9999999995-22-000386 333-262569 22609380 33 1691

Latest XBRL company facts

One latest value per concept from companyfacts (299 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 72.30M 2026-10-29 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
dei EntityPublicFloat Entity Public Float USD 1.30B 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-077442
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 6.90M 2025-01-01 2025-12-31 DEF 14A 2026-04-09 0001140361-26-014002
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.63M 2025-01-01 2025-12-31 DEF 14A 2026-04-09 0001140361-26-014002
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 136.72 2025-01-01 2025-12-31 DEF 14A 2026-04-09 0001140361-26-014002
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 9.13M 2025-01-01 2025-12-31 DEF 14A 2026-04-09 0001140361-26-014002
ecd PeoTotalCompAmt PeoTotalCompAmt USD 6.99M 2025-01-01 2025-12-31 DEF 14A 2026-04-09 0001140361-26-014002
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 261.7 2025-01-01 2025-12-31 DEF 14A 2026-04-09 0001140361-26-014002
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 20.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 11.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AccretionExpenseIncludingAssetRetirementObligations Accretion Expense, Including Asset Retirement Obligations USD 145,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 35.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 257,000 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 5.20M 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010094
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 1.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -704,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.42B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 15.73M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 44.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap Assets Assets USD 465.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AssetsCurrent Assets, Current USD 441.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 384.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 810,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 224,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 328.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 306.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 328.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 55.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 55.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 55.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -299.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap CommonStockValue Common Stock, Value, Issued USD 72,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -325.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap CostOfRevenue Cost of Revenue USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.083 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-07 0000950170-25-064733
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 75.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.119 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023932
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD -66,000 2024-03-31 2024 Q1 10-Q 2024-05-10 0000950170-24-057292
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -1.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 2.03M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212143
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 34,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023932
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 1.58M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 572,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 400,000 2023-02-06 2023 Q3 10-Q 2023-11-09 0000950170-23-062139
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 7.14M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 172.84M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 10.33M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 572,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 84.62M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 379.60M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 406,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 30,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 59.06M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.81M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 916,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 172.27M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 166,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 180.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123239
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 57,000 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD -1.47M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0000950170-24-057292
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 3.07M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021335
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.71 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010094
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.214 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 15.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 58,000 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD -11,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-094108
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD -47,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010094
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016498
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD -454,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 1.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 444,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 20.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 20.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 2.70M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021335
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 91.53M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -299.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -299.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 17,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 64.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -62.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -1.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 64,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -166,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 554,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.29M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 11.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap IncreaseDecreaseInAssetsHeldForSale Increase (Decrease) in Assets Held-for-sale USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 7.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -373,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -478,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 1.91M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023932
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 24.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 20.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InterestExpense Interest Expense USD 3.82M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-094108
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 5.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 21,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004117
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 4.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InterestReceivable Interest Receivable USD 2.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 350,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InventoryGross Inventory, Gross USD 7.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InventoryNet Inventory, Net USD 7.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 5.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 929,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 16.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LeaseCost Lease, Cost USD 761,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.04M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 830,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 254,000 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 254,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 995,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 966,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 179,000 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266881
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 577,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 500,000 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103022
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 1.50M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123239
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 491,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123239
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 1.50M 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 1.50M 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap Liabilities Liabilities USD 132.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 465.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LiabilitiesCurrent Liabilities, Current USD 55.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 45.00M 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016498
us-gaap LongTermDebt Long-term Debt USD 75.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 40.91M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 40.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 34.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap MarketableSecurities Marketable Securities USD 328.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 328.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 11,000 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -305.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -324.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 9.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap NotesPayable Notes Payable USD 75.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 343.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OperatingExpenses Operating Expenses USD 237.62M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -333.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.47M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 549,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.92M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.69M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 360,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 10.20M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.67M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 3.70M 2024-03-31 2024 Q1 10-Q 2024-05-10 0000950170-24-057292
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 10.20M 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.95M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.82M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.75M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 2.67M 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.125 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 341,000 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap OtherAssetsCurrent Other Assets, Current USD 6.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 613,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 29.85M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021335
us-gaap OtherIncome Other Income USD -1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 3,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 286,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123239
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 134,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010094
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap PaymentsForRestructuring Payments for Restructuring USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 23,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 357.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266881
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266881
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266881
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 38.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 2.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 535,000 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 253,000 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap PrepaidInsurance Prepaid Insurance USD 536,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap PrepaidRent Prepaid Rent USD 224,000 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 5.60M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 9.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 400.90M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266881
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 389.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 57,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 550,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 813,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342380
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 88.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PurchaseObligation Purchase Obligation USD 88.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 49.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 38.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 187.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap RestructuringCharges Restructuring Charges USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap RestructuringCosts Restructuring Costs USD 28,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap RestructuringReserve Restructuring Reserve USD 1.60M 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.60M 2022-01-01 2023 Q2 10-Q 2023-08-10 0000950170-23-041399
us-gaap RestructuringReserveNoncurrent Restructuring Reserve, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 136,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.09B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 10.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap SecuredDebt Secured Debt USD 5.00M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023932
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 152.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 44.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.802 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123239
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.876 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.781 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123239
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 180,000 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 63,177 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.12 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 15.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2020-07-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004117
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 2.02M 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 1,654 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 8.92M 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.95M 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 3.08 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 220,042 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212143
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.01 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.92 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 333.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 11.587 2021-05-07 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap StockIssued1 Stock Issued USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 113,683 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-06-24 0001193125-21-198663
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 139.58M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.49M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 48.41M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-28 0000950170-23-010288
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 2.22M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 13,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap SubleaseIncome Sublease Income USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 139.34M 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004701
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 123,000 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036729
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -301,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 535,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 63,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-077442
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 35.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029969
us-gaap VariableLeaseCost Variable Lease, Cost USD 10,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103022
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 71.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 24.23M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010094
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 71.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449826

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →